PRESIDIO PHARMACEUTICALS
Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel therapeutics for viral infections, including HCV and HIV. Presidio has raised over $27 million in financing from Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West, Nexus Medical Partners, and Sagamore Bioventures LLC.
PRESIDIO PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2006-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.presidiopharma.com
Total Employee:
11+
Status:
Active
Contact:
415-655-7560
Email Addresses:
[email protected]
Total Funding:
100.18 M USD
Technology used in webpage:
Rackspace Rackspace Email Hosting UltraDNS Neustar Yahoo Image CDN Yahoo Web Analytics Telepacific Communications UltraDNS Neustar Hosting Yahoo Geocities Analytics
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Current Advisors List
Current Employees Featured
Founder
Investors List
Panorama Capital
Panorama Capital investment in Venture Round - Presidio Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Venture Round - Presidio Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Venture Round - Presidio Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Venture Round - Presidio Pharmaceuticals
Bay City Capital
Bay City Capital investment in Series B - Presidio Pharmaceuticals
Nexus Medical Partners
Nexus Medical Partners investment in Series B - Presidio Pharmaceuticals
Ventures West
Ventures West investment in Series B - Presidio Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series B - Presidio Pharmaceuticals
Panorama Capital
Panorama Capital investment in Series B - Presidio Pharmaceuticals
Sagamore Bioventures
Sagamore Bioventures investment in Series A - Presidio Pharmaceuticals
Official Site Inspections
http://www.presidiopharma.com
- Host name: crs.ultradns.net
- IP address: 204.74.99.100
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
